Protein crystallization by design: chymotrypsinogen without precipitants
about
Crystal Structures of Prethrombin-2 Reveal Alternative Conformations under Identical Solution Conditions and the Mechanism of Zymogen ActivationApplications of the second virial coefficient: protein crystallization and solubility.Protein-protein interactions in dilute to concentrated solutions: α-chymotrypsinogen in acidic conditions.Rapid measurement of protein osmotic second virial coefficients by self-interaction chromatographyProtein-binding RNA aptamers affect molecular interactions distantly from their binding sitesAllostery in trypsin-like proteases suggests new therapeutic strategies.Nonnative protein polymers: structure, morphology, and relation to nucleation and growth.Conformational selection in trypsin-like proteases.Patterns of protein protein interactions in salt solutions and implications for protein crystallization.Roles of conformational stability and colloidal stability in the aggregation of recombinant human granulocyte colony-stimulating factor.Interrelationship of steric stabilization and self-crowding of a glycosylated protein.Application of molecular dynamics simulations in molecular property prediction II: diffusion coefficientThe second virial coefficient as a predictor of protein aggregation propensity: A self-interaction chromatography study.From osmotic second virial coefficient (B22 ) to phase behavior of a monoclonal antibody.Structural role of Gly(193) in serine proteases: investigations of a G555E (GLY193 in chymotrypsin) mutant of blood coagulation factor XI.A continuous-flow mass biosensor for the real-time dynamic analysis of protease inhibition.Extension of coarse-grained UNRES force field to treat carbon nanotubes.
P2860
Q27675359-BCFF7DED-70AB-42C1-B585-23DF7870E46BQ33583320-EBB9D93A-5A7F-405D-90D4-48A4A0A20F18Q33732547-FEAA7C1A-2CC3-4D3A-9DF4-BDD0F4A7ECD5Q34177475-8DB506A3-26D1-4E76-A61E-D1CC4443095BQ35203415-E5E98E1A-F4EB-4BC0-8D00-442CBF8DB0D8Q35317139-82F34979-70A6-446B-A7E0-EF2566974DA2Q36175904-E91967B9-22B9-45DA-86D8-1B56F92F6CCBQ36177002-06C90360-6CA0-48E4-B187-C43918E806B0Q36393549-6D0BF928-1CC4-4CC4-B74B-C2F90D602DF4Q36571961-753DFEDC-18FF-4B35-AA5E-23F7ECAB2B91Q37359372-AE284E0A-4822-4F1A-8159-E1E85493D494Q38708609-8D5B07B8-F424-476C-8F84-CE0313C02DA3Q40640354-9D492973-02AD-450F-91CD-0F440C8CA442Q41433310-62F820FB-0B4D-4AA1-8183-6F21F102D5F0Q44848234-432896B6-2D9F-4ED1-8184-DC7F325DAE4CQ53576566-7DDA0173-5D52-4872-987A-9520C4BF8488Q55027423-3F57D833-7A22-4919-86B3-BE9FAB4E2921
P2860
Protein crystallization by design: chymotrypsinogen without precipitants
description
2000 nî lūn-bûn
@nan
2000 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Protein crystallization by design: chymotrypsinogen without precipitants
@ast
Protein crystallization by design: chymotrypsinogen without precipitants
@en
Protein crystallization by design: chymotrypsinogen without precipitants
@nl
type
label
Protein crystallization by design: chymotrypsinogen without precipitants
@ast
Protein crystallization by design: chymotrypsinogen without precipitants
@en
Protein crystallization by design: chymotrypsinogen without precipitants
@nl
prefLabel
Protein crystallization by design: chymotrypsinogen without precipitants
@ast
Protein crystallization by design: chymotrypsinogen without precipitants
@en
Protein crystallization by design: chymotrypsinogen without precipitants
@nl
P2093
P356
P1476
Protein crystallization by design: chymotrypsinogen without precipitants
@en
P2093
P304
P356
10.1006/JMBI.2000.3851
P407
P577
2000-07-01T00:00:00Z